AG
CORT icon

Algert Global’s Corcept Therapeutics CORT Stock Holding History

Algert Global’s Portfolio CORT Stock Details CORT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$3.31M Buy
+38,040
New +$2.3M 0.04% 698
2026
Q1 		– Sell
-32,058
Closed -$1.12M – 1189
2025
Q4 		$1.12M Sell
32,058
-41,010
-56% -$3.22M 0.02% 828
2025
Q3 		$6.07M Buy
73,068
+31,580
+76% +$2.29M 0.1% 355
2025
Q2 		$3.05M Buy
41,488
+2,160
+5% +$157K 0.06% 491
2025
Q1 		$4.49M Hold
39,328
– – 0.11% 311
2024
Q4 		$1.98M Sell
39,328
-787
-2% -$41.2K 0.05% 611
2024
Q3 		$1.86M Buy
40,115
+27,430
+216% +$975K 0.05% 572
2024
Q2 		$412K Buy
+12,685
New +$347K 0.01% 986
2024
Q1 		– Sell
-122,120
Closed -$3.97M – 1111
2023
Q4 		$3.97M Buy
122,120
+33,960
+39% +$932K 0.16% 207
2023
Q3 		$2.4M Buy
88,160
+5,446
+7% +$158K 0.11% 304
2023
Q2 		$1.84M Buy
82,714
+65,610
+384% +$1.51M 0.08% 413
2023
Q1 		$370K Sell
17,104
-85,520
-83% -$1.87M 0.02% 897
2022
Q4 		$2.08M Buy
102,624
+2,910
+3% +$72.9K 0.12% 282
2022
Q3 		$2.56M Buy
99,714
+6,990
+8% +$187K 0.15% 201
2022
Q2 		$2.21M Buy
92,724
+23,014
+33% +$501K 0.17% 156
2022
Q1 		$1.57M Buy
69,710
+44,790
+180% +$953K 0.1% 323
2021
Q4 		$493K Buy
+24,920
New +$506K 0.06% 544

Other funds holding CORT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ISL
Ingalls & Snyder LLC New York $3.66B AUM 57.76% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Algert Global's CORT Position: Q2 2026 in Review

Algert Global opened a new position in Corcept Therapeutics (CORT) in Q2 2026: 38,040 shares worth $3.31M. The stake represents 0.04% of the portfolio and ranks #698 among its holdings. This is a return to the name: Algert Global previously reported a position in CORT as recently as Q4 2025.

Algert Global first reported a position in CORT in Q4 2021 and has held it in 17 quarters since. The position peaked at $6.07M in Q3 2025. 423 funds tracked by Wall St. Rank hold CORT as of Q2 2026.

  • Algert Global held 38,040 shares of Corcept Therapeutics worth $3.31M as of Q2 2026.
  • Corcept Therapeutics was a new Algert Global position in Q2 2026.
  • Corcept Therapeutics made up 0.04% of Algert Global's portfolio in Q2 2026, its #698 holding.
  • Algert Global first reported a position in Corcept Therapeutics in Q4 2021 and has held it in 17 quarters since.
  • Algert Global's Corcept Therapeutics position peaked at $6.07M in Q3 2025.
  • 423 funds tracked by Wall St. Rank held Corcept Therapeutics as of Q2 2026.

Based on Algert Global's 13F filing for Q2 2026, filed 13 Aug 2026.